Use of HDFx, a Novel Immunomodulator, to Stop the Germs from Winning in Hospitals and on The Battlefields : The Dangers of Antibiotic Resistance
Journal: International Journal of Vaccines and Research (IJVR) (Vol.4, No. 1)Publication Date: 2017-08-18
Authors : Altura BM Altura BT;
Page : 1-2
Keywords : Staphylococcus aureus; Clostridium difficile; drug-resistant; Mycobacterium tuberculosis; Neisseria gonorrhoeae;
Abstract
Getting admitted to a civilian or battlefield hospital these days often poses considerable risks and dangers. The ever-growing number of emerging diseases worldwide makes treatment of patients difficult and sometimes impossible. Many antibiotics are no longer effective against the simplest infections, which result in further hospitalizations with increased costs to the patients and governments worldwide. Microorganisms of prime concern include methicillin-resistant Staphylococcus aureus, Clostridium difficile, multidrug and extensive drug-resistant Mycobacterium tuberculosis, Neisseria gonorrhoeae, and carbapenem- resistant Enterobacteriaceae, as well as bacteria that produce extensive spectram beta-lactamases, such as E. coli. An unusual decline in the discovery of new and effective antibiotics, these days, is only making matters worse.
Other Latest Articles
- Simulation and Control of PV Based Gird Connected Energy Management System Using Drooping Principle
- Support Recovery with Sparsely Sampled Free Random Matrices for Wideband Cognitive Radio Receiver
- Survey on Certificate Revocation in MANET
- Experimental Study – The Use of Bamboo Fiber Using SMA Methodology in Coarse Aggregates
- Effectiveness of using Geotextiles in Flexible Pavements and Life-Cycle Cost Analysis
Last modified: 2017-11-01 00:05:04